Wakayama, Japan

Motoyoshi Osugi


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1981

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Motoyoshi Osugi: Innovator in Anti-Viral Compounds

Introduction

Motoyoshi Osugi is a notable inventor based in Wakayama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with anti-viral properties. With a total of three patents to his name, Osugi's work has garnered attention for its potential impact on health and medicine.

Latest Patents

Osugi's latest patents include innovative compounds that exhibit anti-viral activity while minimizing effects on the central nervous system. One of his notable inventions is the 4-Homoisotwistane-aminoacid amides, which possess a specific chemical structure that allows them to function effectively as anti-viral agents. Another significant patent is the novel tricycloundecane aminoacid amide, which also demonstrates anti-viral properties and is designed to be free from significant central nervous system effects. These advancements highlight Osugi's commitment to creating safer and more effective pharmaceutical solutions.

Career Highlights

Throughout his career, Motoyoshi Osugi has worked with prominent companies in the chemical and pharmaceutical industries. He has been associated with Kao Soap Company, Ltd. and Sumitomo Chemical Company, Limited. His experience in these organizations has contributed to his expertise in developing innovative compounds.

Collaborations

Osugi has collaborated with several talented individuals in his field, including Yoshiaki Inamoto and Eiji Kashihara. These partnerships have likely played a role in enhancing the quality and scope of his research and inventions.

Conclusion

Motoyoshi Osugi is a distinguished inventor whose work in anti-viral compounds has the potential to make a significant impact on public health. His innovative patents and collaborations reflect his dedication to advancing pharmaceutical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…